Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Evaluation of the Efficacy and Safety of VX-864 in Subjects With the PiZZ Genotype: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Efficacy and Safety of VX-864 in Subjects With the PiZZ Genotype: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Evaluation of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with…
- Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Evaluation of the F&P Caramel Nasal Mask, US, 2023: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the F&P Caramel Nasal Mask, US, 2023: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06060717).
- Evaluation of the F&P Toffee Nasal Pillows Mask, US, 2022: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the F&P Toffee Nasal Pillows Mask, US, 2022: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05573763).
- Evaluation of the Healthy Love Workshop, an HIV Prevention Intervention for African American Women: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Healthy Love Workshop, an HIV Prevention Intervention for African American Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1): Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Evaluation of the Immune Responses of GSK Biologicals’ HPV Vaccine Following Manufacturing Process Adaptation.: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Immune Responses of GSK Biologicals' HPV Vaccine Following Manufacturing Process Adaptation.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058): Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Evaluation of the Impact of Nurse-led Telephone on Treatment Compliance: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Impact of Nurse-led Telephone on Treatment Compliance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02483416).
- Evaluation of the Implementation and Effectiveness of IPP-HPV: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Implementation and Effectiveness of IPP-HPV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02994290).
- Evaluation of the Nucleus Hybrid™ L24 Cochlear Implant System: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Nucleus Hybrid™ L24 Cochlear Implant System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00678899).
- Evaluation of the Percutaneous SCS Trial Using the DSSEP Collision Testing: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Percutaneous SCS Trial Using the DSSEP Collision Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluation of the Potential Drug-drug Interactions Between Gemfibrozil or Dabigatran Etexilate and Camlipixant: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Potential Drug-drug Interactions Between Gemfibrozil or Dabigatran Etexilate and Camlipixant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluation of the Safety and Effectiveness of the Kinamed Gem Ceramic Femoral Component for Total Knee Replacement: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Safety and Effectiveness of the Kinamed Gem Ceramic Femoral Component for Total Knee Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Evaluation of the Safety and Efficacy of EXPAREL When Administered Into the TAP in Subjects Undergoing Cesarean Section: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Safety and Efficacy of EXPAREL When Administered Into the TAP in Subjects Undergoing Cesarean Section: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Evaluation of the Safety and Efficacy of Long-term Use of Omega-3 Fatty Acid Ethyl Esters: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Safety and Efficacy of Long-term Use of Omega-3 Fatty Acid Ethyl Esters: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Evaluation of the Safety and Immune Responses of the Towne Strain of CMV in Seronegative Women: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Safety and Immune Responses of the Towne Strain of CMV in Seronegative Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Evaluation of the Safety and Performance of the HARMONI® Toric Lens: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Safety and Performance of the HARMONI® Toric Lens: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluation of the Safety and Tolerability of a Higher Potency Dose of an Investigational Vaccine Among Adults 50 Years of Age and Older (V211-009): Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Safety and Tolerability of a Higher Potency Dose of an Investigational Vaccine Among Adults 50 Years of Age and Older (V211-009): primary endpoint results, effect…
- Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment: primary endpoint results, effect estimate with confidence…
- Evaluation of the Valiant Mona LSA Thoracic Stent Graft System in Descending TAA and Chronic Dissections: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Valiant Mona LSA Thoracic Stent Graft System in Descending TAA and Chronic Dissections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Evaluation of Three Daily Disposable Contact Lenses: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Three Daily Disposable Contact Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02568254).
- Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluation of Umeclidinium Bromide in Combination With Fluticasone Furoate in COPD Subjects With an Asthmatic Component: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Umeclidinium Bromide in Combination With Fluticasone Furoate in COPD Subjects With an Asthmatic Component: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Evaluation of Utility of Ultrasound Guided iPACK Block for Knee Extension After Total Knee Arthroplasty.: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Utility of Ultrasound Guided iPACK Block for Knee Extension After Total Knee Arthroplasty.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Evaluation of Vitamin D Requirements During Pregnancy: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Vitamin D Requirements During Pregnancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00292591).
- Evaluation of VX 445/TEZ/IVA in Cystic Fibrosis Subjects 6 Through 11 Years of Age: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of VX 445/TEZ/IVA in Cystic Fibrosis Subjects 6 Through 11 Years of Age: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Evaluation of VX-659/TEZ/IVA in Cystic Fibrosis Subjects 6 Through 11 Years of Age: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of VX-659/TEZ/IVA in Cystic Fibrosis Subjects 6 Through 11 Years of Age: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluation of Whether Deferiprone Affects QT Interval in Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Whether Deferiprone Affects QT Interval in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01860703).
- EVARIndependent statistical analysis of Combination of E-cigarettes and Varenicline for Tobacco Harm Reduction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04210180).
- EVarQuitIndependent statistical analysis of EVarQuit: Extended Pre-quit Varenicline to Assist in Quitting Smoking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03262662).
- EVAS2Independent statistical analysis of EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EveredIndependent statistical analysis of A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- EVERESTIndependent statistical analysis of EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EVERESTIIRCTIndependent statistical analysis of Pivotal Study of a Percutaneous Mitral Valve Repair System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00209274).
- EVERGREENIndependent statistical analysis of A Study of an Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Respiratory Syncytial Virus (RSV) Vaccine in the Prevention of Lower Respiratory Tract Disease…
- everlinQ endoAVF Post Market Study: Complete Statistical AnalysisIndependent statistical analysis of everlinQ endoAVF Post Market Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02682420).
- Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas: Complete Statistical AnalysisIndependent statistical analysis of Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity: Complete Statistical AnalysisIndependent statistical analysis of Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium: Complete Statistical AnalysisIndependent statistical analysis of Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00805129).
- Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Everolimus for Cancer With TSC1 or TSC2 Mutation: Complete Statistical AnalysisIndependent statistical analysis of Everolimus for Cancer With TSC1 or TSC2 Mutation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02201212).
- Everolimus for Children With Recurrent or Progressive Ependymoma: Complete Statistical AnalysisIndependent statistical analysis of Everolimus for Children With Recurrent or Progressive Ependymoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02155920).
- Everolimus Monotherapy as Immunosuppression After Liver Transplant: Complete Statistical AnalysisIndependent statistical analysis of Everolimus Monotherapy as Immunosuppression After Liver Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04063865).
- Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.: Complete Statistical AnalysisIndependent statistical analysis of Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…